Skip Nav Destination
Issues
1990
ISSN 0378-584X
EISSN 1423-0240
Onkologie 1990, Vol. 13, No. 3
Special Section
Impressum, Vol. 13, No. 3, 1990
Subject Area:
Oncology
Onkologie (1990) 13 (3): 153.
https://doi.org/10.1159/000216749
Inhalt, Vol. 13, No. 3, 1990
Subject Area:
Oncology
Onkologie (1990) 13 (3): 154.
https://doi.org/10.1159/000216750
Übersichtsarbeiten – Review Article
Alternating Chemotherapy in Small Cell Lung Cancer
Subject Area:
Oncology
Onkologie (1990) 13 (3): 157–164.
https://doi.org/10.1159/000216751
Possibilities and Limitations of Immunological Marker Analyses for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
Subject Area:
Oncology
Onkologie (1990) 13 (3): 166–174.
https://doi.org/10.1159/000216752
Originalarbeiten – Original Paper
Phase II Study of Pirarubicin in Metastatic Breast Cancer
Subject Area:
Oncology
U.R. Kleeberg; L. Reichel; H.-E. Wander; J.-H. Beyer; U. Essers; H.H. Fiebig; E. Salewski; B. Greifenberg; L. Edler
Onkologie (1990) 13 (3): 175–179.
https://doi.org/10.1159/000216753
Pirarubicin in Advanced Non-Small Cell Lung Cancer: A Trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society
Subject Area:
Oncology
Onkologie (1990) 13 (3): 180–184.
https://doi.org/10.1159/000216754
Etoposide, Adriamycin, and Cisplatinum (EAP) Combination Chemotherapy for Advanced Gastric Cancer: A Phase II Trial by the “Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)”
Subject Area:
Oncology
U. Räth; H. Flechtner; J. Selbach; H. Harjung; C. Manegold; K. Kabelitz; F.A. Trux; L. Edler; P. Schlag; W. Queißer
Onkologie (1990) 13 (3): 194–197.
https://doi.org/10.1159/000216757
Kombinationstherapie von Adriamycin, Cisplatin und Vindesin beim C-Zell-Karzinom der Schilddrüse
Subject Area:
Oncology
Onkologie (1990) 13 (3): 198–202.
https://doi.org/10.1159/000216758
Bioavailability of Cyclophosphamide in the CMF Regimen
Subject Area:
Oncology
Onkologie (1990) 13 (3): 203–206.
https://doi.org/10.1159/000216759
Erniedrigte Plasmazinkspiegel beim metastasierten Mammakarzinom
Subject Area:
Oncology
Onkologie (1990) 13 (3): 207–209.
https://doi.org/10.1159/000216760
‘Mucin-Like Carcinoma-Associated Antigen’: Sensitivität und Spezifítät beim metastasierten Mammakarzinom
Subject Area:
Oncology
A. Ammon; H. Eiffert; R. Alhusen; M. Weber; B. Rümelin; E. Groh; H. Bartsch; N. Marschner; G.A. Nagel; G. Krieger
Onkologie (1990) 13 (3): 210–214.
https://doi.org/10.1159/000216761
Kasuistiken – Casuistic Contributions
Alpha2-Interferon beim Nierenkarzinom: Erfahrungen an sechs Patienten
Subject Area:
Oncology
Onkologie (1990) 13 (3): 217–220.
https://doi.org/10.1159/000216762
Akute Koronarthrombose und Myokardischämie nach Chemotherapie bei Morbus Hodgkin
Subject Area:
Oncology
Onkologie (1990) 13 (3): 221–224.
https://doi.org/10.1159/000216763
Further Section
Buchbesprechungen – Book Reviews
Subject Area:
Oncology
Onkologie (1990) 13 (3): 225–226.
https://doi.org/10.1159/000216764
Informationen für die Klinik – Clinical Information
Subject Area:
Oncology
Onkologie (1990) 13 (3): 227–230.
https://doi.org/10.1159/000216765
AIO Mitteilungen
Subject Area:
Oncology
Onkologie (1990) 13 (3): 231.
https://doi.org/10.1159/000216766
Hinweise für Autoren – Instructions to Authors
Subject Area:
Oncology
Onkologie (1990) 13 (3): 232.
https://doi.org/10.1159/000216767
